Chronic obstructive lung disease (COPD) is a respiratory disease in which airflow to the lungs is affected. COPD can be life-threatening, and it is not fully reversible with treatment. According to the Global Burden of Disease study, there were as many as 251 million cases of COPD reported in 2016 worldwide, and about 3.17 million deaths were caused by the disease the previous year.
In India alone, the prevalence of this disease is considerably high, with approximately 6.4% of the population reportedly suffering from this illness. With time, the prevalence of the disease has only increased: according to a study published in The Lancet in 2018, the number of cases in India was reported to have been 28.1 million in 1990, but had risen to 55.3 million by 2016.
While chronic respiratory diseases are usually clubbed together for categorisation, COPD includes three progressive conditions in the lungs: chronic bronchitis, emphysema and irreversible asthma. The primary causes of COPD are exposure to pollutants and chemicals and smoking addiction. (Read more: COVID-19 and smoking)
Uncontrolled asthma and a family history of the disease are some risk factor for COPD. People living with COPD may develop comorbidities, including heart disease, depression or diabetes.
Now the new coronavirus infection, COVID-19, is posing another challenge for people living with COPD for at least two reasons:
- Research has shown that people with chronic illnesses are more likely to be severely sick and even die if they contract COVID-19. COPD is, of course, a chronic condition that requires lifelong drug therapy and lifestyle management.
- COVID-19 is a respiratory illness that often affects the lungs. In people with COPD, the health of their lungs is already compromised.
Doctors and medical researchers are, of course, acutely aware that COVID-19 has a bigger impact on people who are already sick—especially those living with conditions that affect the heart, blood vessels and lungs, or with illnesses which cause inflammation such as diabetes and Kawasaki disease. A letter to the peer-reviewed journal Respiratory Medicine pointed out that those suffering from COPD were five times more likely to get the severe symptoms of COVID-19 infection. (Read more: Complications of severe COVID-19 infection)